Gene Query: SPRYD4

Dataset Description Geneva Score
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 34.04
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 22.48
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 15.34
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 15.0
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 14.01
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 14.01
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 13.83
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 13.71
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 13.42
LNCaP treated with iBET 13.21
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 12.53
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 12.19
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 11.68
Identification of HOXB13 target genes responsive to BET inhibitors 11.41
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.38
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.33
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 9.39
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 9.39
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 9.12
HNRNPM-regulated splicing dependencies in prostate cancer 9.12
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 9.02
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 8.72
Identification of global XBP1s target gene expression in human prostate cancer cells 8.59
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.42
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 8.34
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 8.34
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 8.24
4sUDRB-seq: measuring transcription elongation and initiation genomewide 8.24
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 8.11
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.9
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.9
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 7.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 7.68
Effect of CHKA knockdown on C4-2 cell transcriptome 7.63
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 7.26
RNA m5C Methylation in breast cancer using MeRIP-Seq 7.23
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 7.09
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 6.94
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 6.9
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 6.89
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.8
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 6.58
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.58
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.39
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.22
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 6.11
Genome-wide functional assessment of enhancer activities in the human genome 5.99
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.98
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.98
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.98
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.97
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 5.93
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 5.69
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.62
RNA polymerase in pre-B-ALL cell lines 5.62
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 5.56
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 5.55
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 5.48
Evaluating pre-clinical models for studying NASH driven HCC. 5.43
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.4
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.37
Capturing the Interactome of Newly Transcribed RNA 5.37
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 5.37
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.37
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 5.31
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 5.16
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.16
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 5.16
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 5.16
MicroRNA-125a-5p overexpression in human macrophages 5.13
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.08
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 5.0
RNA-seq of IL-4 stimulated human keratinocytes 4.95
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.9
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.85
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.85
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.75
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 4.74
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 4.72
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.7
The Human Testis Cell Atlas via Single-cell RNA-seq 4.7
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.67
U1 snRNP telescripting regulates size-function stratified human genome 4.65
Lipid degradation promotes prostate cancer cell survival 4.6
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.6
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 4.47
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.41
TT-Seq captures the human transient transcriptome 4.39
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 4.38
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 4.38
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 4.31
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.28
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.24
ARS2 is a general suppressor of pervasive transcription [RNAseq] 4.24
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.19
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.18
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 4.15
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 4.15
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.14
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.14
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.07
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.06
T47D RNA-seq and ChrRNA-seq data 4.06
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.02
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 3.95
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.88
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.87
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.87
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.85
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.84
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 3.79
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.79
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.75
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.75
Global expression profiles in cardiac progenitor cells generated by ISX-9 3.75
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 3.75
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.73
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.72
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.67
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 3.64
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.62
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 3.61
AR-independent prostate cancer is sustained through FGF signaling 3.56
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 3.55
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.53
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.52
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 3.52
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.51
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.51
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 3.5
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.49
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.43
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.43
DRB/GRO-Seq -/+ UV 3.39
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 3.39
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 3.39
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 3.37
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.36
Transcriptome profiling of Normal and Cancerous Prostate Cells 3.35
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.35
The evolution of N6-methyladenosine in primates 3.33
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 3.33
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.33
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.28
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 3.22
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 3.22
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.21
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.19
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.17
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 3.1
NKX2.2 3.1
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.04
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.03
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.01
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.01
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 2.98
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.97
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.97
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 2.95
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.92
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 2.92
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.89
Gene expression analysis of human liver progenitor-like cells in culture 2.88
Transcriptional effect of ETV1 knockdown in melanoma cells 2.88
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 2.88
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 2.88
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 2.85
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 2.85
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 2.85
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.84
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.84
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.84
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.83
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.83
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 2.8
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.76
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.76
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.75
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.75
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.75
Genome wide expression change in LCC2 and MCF-7 cells 2.74
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.74
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.74
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 2.72
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 2.72
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 2.71
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 2.71
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 2.71
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.7
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 2.69
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.67
Single-Cell Genotyping of Transcriptomes 2.67
Rorc disruption in human FG pancreatic cancer cells 2.6
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 2.6
Global analysis of enhancer targets: Mosaic-seq 2.59
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.54
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.53
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.5
PRDM1 inhibits proliferation of human colon cancer organoids 2.48
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.48
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.48
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.47
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 2.45
Interphase condensins regulate ligand-depedent enhancer activation 2.45
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.45
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.45
Reassessment of Exosome Composition 2.45
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.44
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.41
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.41
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.39
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.39
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 2.38
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 2.37
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 2.37
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.35
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 2.33
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 2.33
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.32
Targeted enhancer activation by a subunit of the integrator complex 2.31
NRDE2 negatively regulates nuclear exosome functions 2.3
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.3
RNA-seq of tumor cells following angiopellosis extravasation 2.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.3
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.29
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.27
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.26
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.26
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.26
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.26
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.26
Paxillin regulates genomic networks in prostate cancer [LNCaP] 2.26
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.24
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.21
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.21
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.2
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.18
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.18
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.16
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 2.13
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.11
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.1
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.09
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 2.09
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 2.09
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.09
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.09
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.08
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 2.08
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 2.08
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 2.08
Identification of long noncoding RNAs regulated by p53 2.06
Total RNA-seq in ALL-SIL upon JQ1 inhibition 2.05
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.04
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.0
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.99
Oncogenic roles of ARID5B in T-ALL 1.99
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.99
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 1.97
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.92
HNRNPL and its RNA Targets in Prostate Cancer 1.92
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.92
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.87
RNA-seq analysis of control and Myc-induced U2OS cells 1.87
Energy Metabolism during Anchorage-Independence 1.86
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.86
Gene expression in GBM with Cav3.2 inhibition 1.86
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.86
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.85
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.84
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.84
Myc activation coordinates gene transcription and protein translation responses 1.83
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.83
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.83
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.83
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.83
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.82
Chromatin landscape of human visceral and subcutaneous adipocytes 1.82
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 1.8
SLAM-seq for K562 endogenous mRNA decay 1.79
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 1.77
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.77
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 1.76
RNA seq comparison between scrambled and shGRP78 cells 1.76
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.75
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.75
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.75
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.74
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.73
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.73
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.73
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.71
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.7
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.69
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.69
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.68
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.67
quanTIseq: quantifying immune contexture of human tumors 1.65
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.64
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.63
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.62
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.61
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.61
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.6
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.6
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.59
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.58
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.57
Single-cell analysis of adult human ovary using 10X genomics 1.56
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.56
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.55
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.53
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.53
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.52
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.52
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.51
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.51
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.48
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.47
Determining mRNA half-lives on a transcriptome-wide scale 1.43
UV_24h_GRO-Seq 1.43
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 1.43
Cleavage Factor Im as a key regulator of 3’ UTR length 1.42
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 1.42
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.41
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.39
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.36
Recovery and analysis of nascent RNA 1.36
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.36
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.36
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 1.35
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.31
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.28
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.28
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.27
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.27
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.25
Triple vectors expand AAV transfer capacity in the retina 1.24
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.22
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.22
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.21
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.19
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.19
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.19
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.19
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.17
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.16
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.15
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.15
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.14
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.12
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.11
Hepatic transcriptome of pediatric hepatoblastoma. 1.1
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.09
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.09
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.09
HEK293 Heat-shock experiment 1.08
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.07
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.06
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.05
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.04
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.04
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.04
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.03
Hepatocyte maturation 1.03
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 1.03
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.02
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.02
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.01
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.98
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.97
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.97
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.97
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.96
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.96
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.92
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.9
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 0.9
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.89
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.89
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.88
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.88
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.86
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.86
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.84
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.84
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.84
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.82
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.8
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.8
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.8
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.8
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.79
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.78
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.78
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.77
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.77
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.77
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.76
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.74
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.74
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.74
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.73
Gene expression analysis of human hepatocellular cancers 0.73
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.72
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.72
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.72
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.72
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.72
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.72
Transcriptome-wide modulation of splicing by the exon junction complex 0.71
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.7
Androgen Receptor-regulated genes in prostate cancer cells 0.68
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.68
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.66
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.66
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.64
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.64
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.64
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.63
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.63
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.62
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.61
Transcriptional profiling of microglia; current state of the art and future perspectives 0.61
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.59
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.58
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.54
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.53
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.51
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.5
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.47
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.47
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.47
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.47
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.45
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.45
Identification of a LIF-responsive replication-competent human β cell 0.45
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.43
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.42
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.42
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.4
Gene profiling of human adult and pediatric liver cancer cells 0.38
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.37
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.37
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.34
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.34
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.34
RNA-seq of primary patient AML samples 0.32
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.32
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 0.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.3
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.3
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.3
Alagille_Nodder 0.3
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.3
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.3
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.29
Transcriptomic analysis of LSD1 0.28
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.27
Human Tfh cell RNA bulk sequencing 0.27
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.27
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.26
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.24
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.21
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.2
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.2
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.2
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.2
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.19
High-resolution comparative analysis of great ape genomes 0.19
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.19
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.19
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.17
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.15
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.15
CDK4/6 inhibitor resistance in prostate cancer 0.15
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.14
RNA-seq data 0.13
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.13
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.13
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.11
The DNA methylation landscape of human melanoma [RNA-Seq] 0.11
The DNA methylation landscape of human melanoma 0.11
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.11
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.11
The pause-initiation limit restricts transcription activation in human cells 0.1
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.07
Discovering human diabetes-risk gene function with genetics and physiological assays 0.06
Human Treg IFNg/IL-10 subpopulations 0.06
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.05
A single-cell transcriptome atlas of the human pancreas 0.04
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.04
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.03
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.03
Gene expression changes due to PARP knockdown in human cells 0.02
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.0
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation